Skip to content

US · WOK · MEDICAL - SPECIALTIES

WORK Medical Technology Group Ltd. Class A (WOK) intrinsic value and stock valuation

$1.10as of 2026-11-21 · Mkt cap 5.13M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

WORK Medical Technology Group Ltd. Class A DCF and intrinsic value

InvestorsCraft values WOK with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from WOK’s statements →

WORK Medical Technology Group Ltd. Class A Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Specialties Hangzhou, ZH 10158 workmedtech.com

How the business is doing

Fiscal 2020–2025, USD

Revenue
$9.85M-28.5% 5y CAGRd
20202025
Net income
-$-1.07M
20202025
Free cash flow
$4.91M-12.6% 5y CAGRd
20202025
Total equity
$21.2M+29% 5y CAGRd
20202025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2020–2025, USD
20252024202320222021
Revenue$9.85M$11.5M$13.6M$19.7M$45.9M
Operating income-$-2.5M-$-3.7M$490K$1.82M$7.67M
Net income-$-1.07M-$-3.49M$110K$870K$5.96M
EPSd-$-3.69M-$-26.85M$916.7K$7.25M$49.7M
Operating cash flow$6.24M-$-2.23M$2.21M-$-2.26M-$-7.18M
Capital expenditure-$-1.33M-$-9.26M-$-580K-$-2.01M-$-60K
Free cash flow$4.91M-$-11.49M$1.63M-$-4.27M-$-7.24M
Total assets$33.2M$36.3M$30M$25.5M$30.7M
Total debt$6.45M$13.5M$9.1M$6.3M$6.6M
Net debt$2.36M$6.91M$7.5M$5.57M$6.09M
Total equity$21.2M$16.1M$11M$11.2M$11.4M
Cash and short-term investments$4.09M$6.56M$1.6M$730K$510K
Income statement
20252024202320222021
Revenue$9.85M$11.5M$13.6M$19.7M$45.9M
Cost of revenue$7.5M$8.64M$9.42M$15.3M$37.2M
Gross profit$2.34M$2.87M$4.14M$4.42M$8.64M
Research and development expenses$440K$300K$300K$180K$190K
Selling, general and administrative expenses$4.41M$6.61M$3.43M$3.6M$4.49M
Other expenses$0.00-$-350K-$-70K-$-1.19M-$-3.71M
Operating expenses$4.84M$6.57M$3.66M$2.59M$970K
Cost and expenses$12.3M$15.2M$13.1M$17.9M$38.2M
Interest income$180K$10K$0.00$0.00$0.00
Interest expense$500K$560K$370K$350K$330K
Depreciation and amortization$920K$1.39M$1.6M$3.26M$4.19M
Ebitda$340K-$-1.71M$2.08M$4.72M$11.9M
Operating income-$-2.5M-$-3.7M$490K$1.82M$7.67M
Total other income/expenses, net$1.41M$380K-$-380K$480K$3.38M
Income before tax-$-1.08M-$-3.67M$110K$1.11M$7.34M
Income tax expense$120K-$-130K$50K$170K$1.08M
Net income-$-1.07M-$-3.49M$110K$870K$5.96M
Weighted average shares outstanding$290K$130K$130K$130K$130K
Weighted average diluted shares outstanding$290K$130K$120K$120K$120K
Balance sheet
20252024202320222021
Cash and short-term investments$4.09M$6.56M$1.6M$730K$510K
Net receivables$12.5M$5.75M$11M$6.15M$6.57M
Inventory$3.68M$3.18M$4.62M$4.36M$6.29M
Total current assets$20.5M$20.8M$22.2M$16.6M$18.2M
Property, plant and equipment, net$10.6M$14.3M$6.74M$7.98M$11.5M
Goodwill and intangible assets$960K$1.04M$1M$950K$1.06M
Long-term investments$10K$0.00$0.00$0.00$0.00
Total non-current assets$12.7M$15.4M$7.81M$8.93M$12.5M
Total assets$33.2M$36.3M$30M$25.5M$30.7M
Accounts payable$1.72M$1.5M$3.96M$3.2M$9.04M
Short-term debt$6.41M$13.5M$9.05M$6.23M$6.6M
Deferred revenue$400K$630K$780K$740K$1.59M
Total current liabilities$12M$20.2M$18.9M$14.3M$18.9M
Long-term debt$40K$0.00$50K$70K$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$20K$140K$50K$90K$350K
Capital lease obligations$20K$0.00$100K$90K$0.00
Total liabilities$12M$20.2M$19M$14.4M$19.3M
Common stock$50K$10K$10K$10K$50K
Retained earnings$4.96M$6.08M$9.58M$9.51M$8.74M
Accumulated other comprehensive income (loss)$290K$490K$210K$410K$1.21M
Total equity$21.2M$16.1M$11M$11.2M$11.4M
Total investments$10K$0.00$0.00$0.00$0.00
Total debt$6.45M$13.5M$9.1M$6.3M$6.6M
Net debt$2.36M$6.91M$7.5M$5.57M$6.09M
Cash flow statement
20252024202320222021
Net income-$-1.07M-$-3.49M$60K$940K$6.27M
Depreciation and amortization$920K$1.39M$1.6M$3.26M$4.19M
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital$6.44M-$-110K$460K-$-7.13M-$-18.16M
Accounts receivable$1.02M$1.82M-$-130K-$-3.96M-$-120K
Inventory$570K$1.58M-$-400K$2.05M$6.89M
Accounts payable$250K-$-2.55M$860K-$-5.82M-$-2.94M
Net cash provided by operating activities$6.24M-$-2.23M$2.21M-$-2.26M-$-7.18M
Investments in property, plant and equipment-$-1.33M-$-9.23M-$-460K-$-2.01M-$-60K
Acquisitions, net$390K$0.00$0.00$60K$0.00
Net cash used for investing activities-$-7.61M-$-9.06M-$-580K-$-1.35M-$-60K
Common stock issued$6.9M$7.37M$0.00$0.00$790K
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-900K$15.7M-$-730K$3.57M$7.99M
Net change in cash-$-2.87M$4.92M$860K-$-100K$670K
Cash at end of period$4.09M$6.56M$1.64M$770K$870K
Operating cash flow$6.24M-$-2.23M$2.21M-$-2.26M-$-7.18M
Capital expenditure-$-1.33M-$-9.26M-$-580K-$-2.01M-$-60K
Free cash flow$4.91M-$-11.49M$1.63M-$-4.27M-$-7.24M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About WORK Medical Technology Group Ltd. Class A

        WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.

        CEO
        Shuang Wu
        Employees
        238
        Beta
        1.74

        Explore

        Frequently asked questions

        What is the intrinsic value of WORK Medical Technology Group Ltd. Class A (WOK)?

        InvestorsCraft does not currently publish an intrinsic value for WOK. How the IC value is calculated.

        Is WOK undervalued?

        InvestorsCraft does not publish an undervaluation signal for WOK at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.